DUSA Pharmaceuticals Reports Results From Phase II Clinical Trial For PDT Of Moderate To Severe Acne; Shares Plummet On Acne Study

The results of the study indicate that both ‘Levulan BLU-U’ and ‘BLU-U alone’ appear to effectively reduce the number of both inflammatory and non-inflammatory acne lesions. However, in the subset of patients with greater than 60 inflammatory lesions at baseline, ‘Levulan BLU-U’ appeared to be more effective than ‘BLU-U alone’. Treatment was well tolerated in both arms of the study with no unanticipated adverse events being reported.